一种基于VLP的mRNA疫苗引起了对Oropouche病毒的强有力的幽默和细胞免疫力

Yuren Shi1, Guangxu Zhang1, Siyu Lin2

  • 1Key Laboratory of Medical Molecular Virology (Ministry of Education/National Health Commission/Chinese Academy of Medical Science), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

mBio
|January 12, 2026
PubMed
概括

使用Oropouche病毒 (OROV) 病毒样颗粒 (VLPs) 的新型mRNA疫苗显示出对抗重新出现的OROV威胁的希望. 这种疫苗引起强大的中和抗体和细胞免疫力,对各种OROV菌株,提供一个潜在的宽频对策.